{"id":4684,"date":"2026-08-10T19:58:55","date_gmt":"2026-08-10T19:58:55","guid":{"rendered":"https:\/\/anhaber.net\/?p=4684"},"modified":"2026-08-10T19:58:56","modified_gmt":"2026-08-10T19:58:56","slug":"sanovel-ilacta-disa-bagimliligi-azaltmayi-hedefliyor","status":"publish","type":"post","link":"https:\/\/anhaber.net\/?p=4684","title":{"rendered":"Sanovel, ila\u00e7ta d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 azaltmay\u0131 hedefliyor"},"content":{"rendered":"\n

H\u00dcLYA YALIN: “43 YILDIR T\u00dcRK\u0130YE\u2019DEN ALDI\u011eIMIZ G\u00dc\u00c7LE B\u00dcY\u00dcYORUZ”<\/strong><\/p>\n\n\n\n

T\u00fcrkiye ila\u00e7 sekt\u00f6r\u00fcn\u00fcn lider \u015firketlerinden Sanovel, uluslararas\u0131 yat\u0131r\u0131mlarla g\u00fc\u00e7lenen yap\u0131s\u0131, Ar-Ge yat\u0131r\u0131mlar\u0131 ve ihracat odakl\u0131 b\u00fcy\u00fcme stratejisiyle k\u00fcresel ila\u00e7 pazar\u0131ndaki y\u00fckseli\u015fine ivme kazand\u0131r\u0131yor. \u015eirket, 2035 vizyonu do\u011frultusunda etki alan\u0131n\u0131 2 kat\u0131na \u00e7\u0131karmay\u0131 ve onkoloji hamlesiyle T\u00fcrkiye\u2019nin ila\u00e7ta d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltmay\u0131 hedefliyor.<\/strong><\/p>\n\n\n\n

Sanovel\u2019in CEO\u2019su H\u00fclya Yal\u0131n, \u015firketin sahip oldu\u011fu k\u00f6kl\u00fc birikim ve \u00fcretim g\u00fcc\u00fcyle halihaz\u0131rda \u00f6nemli bir konumda bulundu\u011funu vurgulayarak, uluslararas\u0131 yat\u0131r\u0131mc\u0131lar\u0131n sa\u011flad\u0131\u011f\u0131 deste\u011fin bu g\u00fc\u00e7l\u00fc yap\u0131y\u0131 daha da ileri ta\u015f\u0131d\u0131\u011f\u0131n\u0131 ifade etti. <\/p>\n\n\n\n

Yal\u0131n, s\u00f6z konusu yat\u0131r\u0131mlar\u0131n Sanovel\u2019in k\u00fcresel ila\u00e7 pazar\u0131ndaki y\u00fckseli\u015fine ivme kazand\u0131r\u0131rken, T\u00fcrkiye\u2019yi daha g\u00fc\u00e7l\u00fc bir \u00fcretim ve ihracat \u00fcss\u00fc haline getirme hedeflerine de katk\u0131 sa\u011flad\u0131\u011f\u0131n\u0131; ayn\u0131 zamanda \u00fclkeye giren do\u011frudan yabanc\u0131 yat\u0131r\u0131m\u0131n, T\u00fcrkiye\u2019nin ila\u00e7ta d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltma vizyonunu destekleyen \u00f6nemli bir unsur oldu\u011funu belirtti. Yal\u0131n, k\u00fcresel yat\u0131r\u0131mc\u0131lar\u0131n T\u00fcrkiye ekonomisine ve ila\u00e7 sanayisinin potansiyeline duydu\u011fu g\u00fcvenin bir kez daha ortaya kondu\u011funu vurgulad\u0131. Bu stratejik hamlenin, T\u00fcrkiye\u2019nin yerli \u00fcretim g\u00fcc\u00fcn\u00fc ve k\u00fcresel pazarlardaki konumunu bir \u00fcst seviyeye ta\u015f\u0131yaca\u011f\u0131n\u0131 da s\u00f6zlerine ekledi.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

“43 y\u0131ld\u0131r T\u00fcrkiye\u2019den ald\u0131\u011f\u0131m\u0131z g\u00fc\u00e7le b\u00fcy\u00fcyoruz”<\/strong><\/p>\n\n\n\n

Sanovel CEO\u2019su H\u00fclya Yal\u0131n, \u015firketin ge\u00e7mi\u015fi, kurumsal yap\u0131s\u0131 ve mevcut operasyonel b\u00fcy\u00fckl\u00fc\u011f\u00fcne ili\u015fkin \u015fu bilgileri payla\u015ft\u0131:<\/p>\n\n\n\n

“Sanovel, temelleri 1983 y\u0131l\u0131nda merhum Eczac\u0131 Erol Toks\u00f6z taraf\u0131ndan at\u0131lm\u0131\u015f, 43 y\u0131ld\u0131r T\u00fcrkiye ila\u00e7 sanayisinin geli\u015fimine \u00f6nc\u00fcl\u00fck eden lider \u015firketlerden biridir. K\u00f6kleri bu topraklarda olan Sanovel, \u015feffafl\u0131k, kalite, bilim ve insan odakl\u0131 de\u011ferlerden \u00f6d\u00fcn vermeden b\u00fcy\u00fcm\u00fc\u015f; bug\u00fcn hem \u00fclkemiz hem de k\u00fcresel pazarlar i\u00e7in son derece g\u00fcvenilir bir \u00e7\u00f6z\u00fcm orta\u011f\u0131 haline gelmi\u015ftir. G\u00fcc\u00fcn\u00fc T\u00fcrkiye\u2019den alan, y\u00fczde 100 yerli \u00fcretimiyle \u00fclkemizin sa\u011fl\u0131k ekosistemindeki konumunu her ge\u00e7en g\u00fcn daha da kuvvetlendiren bir T\u00fcrk \u015firketiyiz. Faaliyetlerimizi T\u00fcrkiye merkezli olarak s\u00fcrd\u00fcr\u00fcyor; Ar-Ge\u2019mizi, \u00fcretimimizi, kalite s\u00fcre\u00e7lerimizi ve t\u00fcm ihracat operasyonlar\u0131m\u0131z\u0131 \u0130stanbul Levent\u2019teki Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fcm\u00fcz ile Silivri\u2019deki y\u00fcksek teknolojili Ar-Ge Merkezi ve \u00dcretim Kamp\u00fcs\u00fcm\u00fczden y\u00f6netiyoruz. Bug\u00fcn yakla\u015f\u0131k 2 bin ki\u015fiye istihdam sa\u011flayan g\u00fc\u00e7l\u00fc yap\u0131m\u0131zla hareket ediyoruz. 43 y\u0131ld\u0131r T\u00fcrkiye\u2019den ald\u0131\u011f\u0131m\u0131z g\u00fc\u00e7le b\u00fcy\u00fcrken, \u00fclkemizi d\u00fcnyada en iyi \u015fekilde temsil etmeyi milli bir sorumluluk olarak g\u00f6r\u00fcyoruz.”<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

“60’tan fazla marka, 400’\u00fcn \u00fczerinde ruhsatl\u0131 \u00fcr\u00fcn”<\/strong><\/p>\n\n\n\n

Yerli \u00fcretimin d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 azaltmadaki rol\u00fcn\u00fc ve Silivri’deki \u00fcretim \u00fcss\u00fcn\u00fc vurgulayan Yal\u0131n, portf\u00f6y yap\u0131s\u0131n\u0131 \u015f\u00f6yle aktard\u0131:<\/p>\n\n\n\n

“Biz yerli \u00fcretimi desteklemeyi ve T\u00fcrkiye\u2019nin ila\u00e7ta d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltmay\u0131 kurumsal bir \u00f6devden \u00f6te, milli bir g\u00f6rev olarak kabul ediyoruz. \u00dcr\u00fcn portf\u00f6y\u00fcm\u00fcz\u00fcn tamam\u0131 re\u00e7eteli ila\u00e7lardan olu\u015fuyor. A\u011fr\u0131 ve inflamasyon, endokrin ve metabolizma, gastrointestinal, hematoloji, hepatoloji, kardiyovask\u00fcler, multipl skleroz (MS), n\u00f6roloji ve psikiyatri gibi akut ve kronik tedavi alanlar\u0131nda faaliyet g\u00f6steriyoruz. 60\u2019tan fazla marka ve 180\u2019i a\u015fk\u0131n \u00fcr\u00fcnden olu\u015fan \u00e7ok geni\u015f bir \u00fcr\u00fcn portf\u00f6y\u00fcne sahibiz. Toplamda 400\u2019\u00fcn \u00fczerinde ruhsatl\u0131 \u00fcr\u00fcn\u00fcm\u00fcz bulunuyor. En b\u00fcy\u00fck gurur kaynaklar\u0131m\u0131zdan biri, bir\u00e7ok tedavi alan\u0131nda pazara ilk e\u015fde\u011fer \u00fcr\u00fcn sunan \u015firket konumunda olmam\u0131zd\u0131r. T\u00fcm bu faaliyetlerin kalbi Silivri\u2019deki tesisimizde at\u0131yor. Buras\u0131 yakla\u015f\u0131k 800 ekip arkada\u015f\u0131m\u0131z\u0131n emekleriyle neredeyse t\u00fcm formlarda ila\u00e7 \u00fcretimi ger\u00e7ekle\u015ftirebildi\u011fimiz, T\u00fcrkiye\u2019nin adeta bir Ar-Ge ve \u00fcretim \u00fcss\u00fcd\u00fcr. T\u00fcrkiye\u2019nin yan\u0131 s\u0131ra 5 k\u0131tada 50\u2019den fazla \u00fclkenin de ila\u00e7 ihtiyac\u0131n\u0131 her ko\u015fulda g\u00fcvenle kar\u015f\u0131l\u0131yoruz.”<\/p>\n\n\n\n

Rakamlarla Sanovel ve onkoloji hamlesi<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Son 5 y\u0131ldaki b\u00fcy\u00fcme rakamlar\u0131n\u0131 ve 2035 vizyonunu detayland\u0131ran Yal\u0131n \u015fu verileri payla\u015ft\u0131: “IQVIA\u2019ya g\u00f6re de\u011fer baz\u0131nda 10,5 kat, kutu baz\u0131nda ise 1,5 kat b\u00fcy\u00fcme g\u00f6sterdik. Diyabet alan\u0131nda jenerik firmalar aras\u0131nda lider konumday\u0131z. Kardiyoloji alan\u0131nda jenerik firmalar aras\u0131nda 2. s\u0131rada, merkezi sinir sistemi alan\u0131nda ise total pazarda ikinci s\u0131raday\u0131z. MS pazar\u0131nda ise jenerik firmalar aras\u0131nda 2. s\u0131rada, total pazarda ise 3. s\u0131rada yer al\u0131yoruz.<\/p>\n\n\n\n

Yurt i\u00e7i pazarda y\u00fckseli\u015fimizi s\u00fcrd\u00fcr\u00fcrken uluslararas\u0131 pazarlarda ihracat\u0131m\u0131z\u0131 yakla\u015f\u0131k 4 kat b\u00fcy\u00fctt\u00fck. \u00dcretim miktar\u0131m\u0131z\u0131 60 milyon kutudan 91,5 milyon kutuya ta\u015f\u0131d\u0131k. Son 5 y\u0131lda fabrikam\u0131za yapt\u0131\u011f\u0131m\u0131z 26 milyon ABD dolar\u0131 yat\u0131r\u0131mla yeni ekipmanlar temin ettik. 2035 vizyonumuz do\u011frultusunda verimlilik ve s\u00fcrd\u00fcr\u00fclebilirlik odakl\u0131 bir gelecek plan\u0131yla ilerliyoruz. Olu\u015fturdu\u011fumuz proje tak\u0131mlar\u0131ndan biri onkoloji oda\u011f\u0131nda faaliyet g\u00f6steriyor. \u00c7o\u011funlu\u011fu ithal olan onkoloji \u00fcr\u00fcnlerini \u00fclkemizde \u00fcreterek bu \u00fcr\u00fcnlerin eri\u015filebilirli\u011fini art\u0131rmay\u0131, s\u00fcrd\u00fcr\u00fclebilir sa\u011fl\u0131\u011fa katk\u0131 sunmay\u0131 ve \u00fclkemizin d\u00f6viz kaynaklar\u0131n\u0131n korunmas\u0131na destek olmay\u0131 \u00f6nemsiyoruz. 2035 vizyonumuz kapsam\u0131nda etki alan\u0131m\u0131z\u0131 2 kat\u0131na \u00e7\u0131karmay\u0131, orta vadede T\u00fcrk ila\u00e7 pazar\u0131nda ilk 10 firma aras\u0131nda yer almay\u0131 ve yurt d\u0131\u015f\u0131nda Sanovel markas\u0131n\u0131 k\u00fcresel bir dev haline getirmeyi hedefliyoruz.”<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

K\u00fcresel pazarlardaki varl\u0131klar\u0131 ve uluslararas\u0131 denetim ba\u015far\u0131lar\u0131 hakk\u0131nda konu\u015fan Yal\u0131n \u015funlar\u0131 aktard\u0131: “2005 y\u0131l\u0131nda ba\u015flad\u0131\u011f\u0131m\u0131z ihracat yolculu\u011funu bug\u00fcn \u00e7ok ileri bir boyuta ta\u015f\u0131d\u0131k. \u015eu anda 400\u2019\u00fcn \u00fczerinde ruhsat ile Kanada\u2019dan ABD ve Avrupa\u2019ya kadar 50 \u00fclkedeki ihracat faaliyetlerimizi s\u00fcrd\u00fcr\u00fcyoruz. T\u00fcrkiye\u2019nin cari a\u00e7\u0131\u011f\u0131n\u0131n azalt\u0131lmas\u0131na ve net d\u00f6viz girdisi sa\u011flanmas\u0131na stratejik bir destek sunuyoruz. Fabrikam\u0131zdaki s\u00fcre\u00e7lerin uluslararas\u0131 standartlara uygunlu\u011funu Avrupa\u2019da EMA ve EU GMP, ABD\u2019de ise US FDA onaylar\u0131m\u0131zla tescillemi\u015f olmaktan gurur duy\u0131yoruz. \u015eu an bulundu\u011fumuz ve yeni giri\u015f yapmay\u0131 planlad\u0131\u011f\u0131m\u0131z pazarlarda 200\u2019den fazla ruhsat onay\u0131 bekliyoruz. Gelecek hedeflerimiz do\u011frultusunda AB, ABD, Kanada, MENA, Sahra Alt\u0131 Afrika, G\u00fcneydo\u011fu Asya, LATAM ve CIS b\u00f6lgelerinde varl\u0131\u011f\u0131m\u0131z\u0131 geni\u015fletmeye odaklan\u0131yoruz.”<\/p>\n\n\n\n

“50 \u00fclkede var\u0131z, 200’den fazla ruhsat onay\u0131 bekliyoruz”<\/strong><\/p>\n\n\n\n

Ar-Ge kadrosu ve teknolojik altyap\u0131ya ili\u015fkin a\u00e7\u0131klamalarda bulunan CEO H\u00fclya Yal\u0131n \u015f\u00f6yle devam etti: “80 bilim insan\u0131yla Ar-Ge \u00e7al\u0131\u015fmalar\u0131n\u0131 y\u00fcr\u00fcten Sanovel olarak, sekt\u00f6rde Ar-Ge\u2019ye en fazla kaynak ay\u0131ran lider \u015firketlerden biriyiz. Alman m\u00fchendislik \u015firketi PharmaPlan taraf\u0131ndan tasarlanan tesisimizdeki Ar-Ge Merkezimizde; konvansiyonel ila\u00e7lar\u0131n \u00f6tesine ge\u00e7erek kombinasyon \u00fcr\u00fcnler, yeni \u00fcretim teknolojileriyle farkl\u0131 dozaj \u015fekilleri i\u00e7eren \u00fcr\u00fcnler ve ODT (a\u011f\u0131zda da\u011f\u0131lan tablet) projeleri geli\u015ftiriyoruz. Bu projeleri T\u00fcrkiye, ABD, Kanada ve Avrupa pazarlar\u0131 i\u00e7in ‘ilk e\u015fde\u011fer’ olma hedefiyle kurguluyoruz. \u00c7al\u0131\u015fmalar\u0131m\u0131zda cGMP ve cGLP kurallar\u0131n\u0131 en \u00fcst seviyede uygularken, Kalite Tasar\u0131m\u0131 (QbD) yakla\u015f\u0131m\u0131yla reg\u00fcle pazarlar\u0131n kap\u0131s\u0131n\u0131 a\u00e7\u0131yoruz. Fikri m\u00fclkiyet ve patent alan\u0131nda ila\u00e7 sekt\u00f6r\u00fcnde elde etti\u011fimiz \u015fampiyonlu\u011fu bu yo\u011fun eme\u011fin sonucu olarak g\u00f6r\u00fcyoruz. T\u00fcrkiye\u2019deki t\u00fcm sekt\u00f6rler baz\u0131nda yap\u0131lan patent ba\u015fvuru say\u0131s\u0131 s\u0131ralamalar\u0131nda ilk 3 \u015firket aras\u0131nda yer al\u0131yoruz.”<\/p>\n\n\n\n

S\u00fcrd\u00fcr\u00fclebilirlik, Sosyal Sorumluluk ve “En \u0130yi \u0130\u015fveren” \u00d6d\u00fcl\u00fc<\/strong><\/p>\n\n\n\n

\u00c7evresel hedefler, sosyal projeler ve insan kaynaklar\u0131 ba\u015far\u0131lar\u0131na de\u011finen Yal\u0131n t\u00fcm faaliyetlerinde Birle\u015fmi\u015f Milletler K\u00fcresel \u0130lkeler S\u00f6zle\u015fmesi ve S\u00fcrd\u00fcr\u00fclebilir Kalk\u0131nma Ama\u00e7lar\u0131\u2019n\u0131 rehber ald\u0131klar\u0131n\u0131 ifade ederek, \u201c\u00c7evresel performans\u0131m\u0131z\u0131 d\u00fczenli takip ederek 2025 y\u0131l\u0131nda karbon ayak izimizde y\u00fczde 14,3, su ayak izimizde ise y\u00fczde 13,9 oran\u0131nda net azalt\u0131m sa\u011flad\u0131k. Cumhuriyetimizin 102. y\u0131l\u0131nda 102 k\u0131z \u00f6\u011frencimize profesyonel ko\u00e7luk deste\u011fi sa\u011flad\u0131k. F\u0131rsat E\u015fitli\u011fi Modeli Sertifikas\u0131\u2019n\u0131 almaya hak kazanarak toplumsal cinsiyet e\u015fitli\u011fi yakla\u015f\u0131m\u0131m\u0131z\u0131 tescilledik. Ayr\u0131ca Forbes T\u00fcrkiye ve Statista i\u015f birli\u011fiyle ger\u00e7ekle\u015ftirilen ‘T\u00fcrkiye\u2019nin En \u0130yi \u0130\u015fverenleri 2026’ listesinde yer almaktan memnuniyet duyuyoruz. 10 binden fazla \u00e7al\u0131\u015fan\u0131n anonim geri bildirimleri do\u011frultusunda olu\u015fturulan bu listede yer almak, \u00e7al\u0131\u015fan deneyimine verdi\u011fimiz \u00f6nemin bir g\u00f6stergesidir\u201d diye konu\u015ftu.<\/p>\n\n\n\n

\u201cT\u00fcrkiye\u2019yi global arenada en iyi \u015fekilde temsil etmeye devam ediyoruz\u201d<\/strong><\/p>\n\n\n\n

\u015eirketin devredildi\u011fi veya de\u011ferinin alt\u0131nda sat\u0131ld\u0131\u011f\u0131 y\u00f6n\u00fcndeki iddialara a\u00e7\u0131kl\u0131k getiren Yal\u0131n, \u015fu ifadeleri kulland\u0131: “\u00d6ncelikle \u00e7ok net ifade etmek isterim ki, Sanovel ile ilgili ortaya at\u0131lan iddialar ger\u00e7e\u011fi yans\u0131tmamaktad\u0131r. Sanovel, bir T\u00fcrk \u015firketi olarak 43 y\u0131ld\u0131r oldu\u011fu gibi bug\u00fcn de \u00fclkesi i\u00e7in yat\u0131r\u0131m yapmaya, istihdam yaratmaya, T\u00fcrkiye\u2019yi global arenada en iyi \u015fekilde temsil etmeye devam etmektedir. Her \u015firkette oldu\u011fu gibi Sanovel\u2019in idari s\u00fcre\u00e7leriyle ilgili olu\u015fan de\u011fi\u015fimler, \u015firketimizin g\u00fc\u00e7l\u00fc gelece\u011fini desteklemek, operasyonel m\u00fckemmeliyet ve organizasyonel \u00e7evikli\u011fi g\u00fc\u00e7lendirmek ad\u0131na at\u0131lan do\u011fal d\u00f6n\u00fc\u015f\u00fcm ad\u0131mlar\u0131d\u0131r. D\u00f6nem d\u00f6nem g\u00fcndeme getirilen ge\u00e7mi\u015f hissedarlar\u0131m\u0131zla ilgili s\u00fcre\u00e7ler ise Sanovel\u2019in t\u00fczel ki\u015fili\u011fini ve bug\u00fcnk\u00fc operasyonel faaliyetlerini ilgilendiren bir konu de\u011fildir. Uluslararas\u0131 yat\u0131r\u0131mc\u0131lardan g\u00f6sterilen ilgi, hem \u00fclkemizin makroekonomik istikrar\u0131na hem de Sanovel’in k\u00fcresel potansiyeline duyulan sars\u0131lmaz g\u00fcvenin bir yans\u0131mas\u0131d\u0131r.”<\/p>\n\n\n\n

“Uluslararas\u0131 Yat\u0131r\u0131m T\u00fcrkiye’nin \u00dcretim G\u00fcc\u00fcn\u00fcn Tescilidir”<\/strong><\/p>\n\n\n\n

Uluslararas\u0131 ortakl\u0131\u011f\u0131n sa\u011flad\u0131\u011f\u0131 katk\u0131ya de\u011finen H\u00fclya Yal\u0131n \u015funlar\u0131 ekledi: “Uluslararas\u0131 yat\u0131r\u0131mc\u0131lar\u0131n hissedarlar aras\u0131nda yer almas\u0131, T\u00fcrk ila\u00e7 sekt\u00f6r\u00fcn\u00fcn ve T\u00fcrkiye\u2019nin \u00fcretim g\u00fcc\u00fcn\u00fcn uluslararas\u0131 arenada ne kadar b\u00fcy\u00fck bir itici g\u00fc\u00e7 oldu\u011funun tescilidir. 2020 y\u0131l\u0131 ve sonras\u0131nda ger\u00e7ekle\u015fen bu stratejik yat\u0131r\u0131m; \u015firketimizin \u00fcretim g\u00fcc\u00fcn\u00fc, Ar-Ge kabiliyetini, istihdam\u0131n\u0131, ihracat potansiyelini ve yerli \u00fcretime olan katk\u0131s\u0131n\u0131 \u00e7ok daha yukar\u0131lara ta\u015f\u0131yacak hayati bir ad\u0131m olmu\u015ftur. Sanovel, 2020 y\u0131l\u0131 itibar\u0131yla kurumsalla\u015fma yolculu\u011funu stratejik yat\u0131r\u0131mlarla halihaz\u0131rda g\u00fc\u00e7lendirmeye ba\u015flam\u0131\u015f; b\u00fcy\u00fcme, globalle\u015fme, s\u00fcrd\u00fcr\u00fclebilirlik hedeflerinde \u00f6nemli at\u0131l\u0131mlar ger\u00e7ekle\u015ftirmi\u015fti. Uluslararas\u0131 yat\u0131r\u0131mc\u0131lar\u0131n sa\u011flad\u0131\u011f\u0131 bu yeni katk\u0131 ve g\u00fcven ortam\u0131, k\u00fcresel pazarlardaki rekabet g\u00fcc\u00fcm\u00fcz\u00fc \u00e7ok daha fazla geli\u015ftirecek ve per\u00e7inleyecektir. Sanovel bu \u00fclkenin milli bir de\u011feridir ve gelece\u011fini kararl\u0131l\u0131kla T\u00fcrkiye\u2019de in\u015fa etmektedir.”<\/p>\n","protected":false},"excerpt":{"rendered":"

H\u00dcLYA YALIN: “43 YILDIR T\u00dcRK\u0130YE\u2019DEN ALDI\u011eIMIZ G\u00dc\u00c7LE B\u00dcY\u00dcYORUZ” T\u00fcrkiye ila\u00e7 sekt\u00f6r\u00fcn\u00fcn lider \u015firketlerinden Sanovel, uluslararas\u0131 yat\u0131r\u0131mlarla g\u00fc\u00e7lenen yap\u0131s\u0131, Ar-Ge yat\u0131r\u0131mlar\u0131 ve ihracat odakl\u0131 b\u00fcy\u00fcme stratejisiyle k\u00fcresel ila\u00e7 pazar\u0131ndaki y\u00fckseli\u015fine ivme kazand\u0131r\u0131yor. \u015eirket, 2035 vizyonu do\u011frultusunda etki alan\u0131n\u0131 2 kat\u0131na \u00e7\u0131karmay\u0131 ve onkoloji hamlesiyle T\u00fcrkiye\u2019nin ila\u00e7ta d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltmay\u0131 hedefliyor. Sanovel\u2019in CEO\u2019su H\u00fclya Yal\u0131n, \u015firketin sahip […]<\/p>\n","protected":false},"author":3,"featured_media":4689,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,45,9],"tags":[],"class_list":["post-4684","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-is-haberleri","category-manset","category-saglik-haberleri"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/posts\/4684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/anhaber.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4684"}],"version-history":[{"count":1,"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/posts\/4684\/revisions"}],"predecessor-version":[{"id":4690,"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/posts\/4684\/revisions\/4690"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/anhaber.net\/index.php?rest_route=\/wp\/v2\/media\/4689"}],"wp:attachment":[{"href":"https:\/\/anhaber.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/anhaber.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/anhaber.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}